| Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases A Shukla, M Gulumian, TK Hei, D Kamp, Q Rahman, BT Mossman Free Radical Biology and Medicine 34 (9), 1117-1129, 2003 | 335 | 2003 |
| Dissolution and biodurability: Important parameters needed for risk assessment of nanomaterials W Utembe, K Potgieter, AB Stefaniak, M Gulumian Particle and fibre toxicology 12, 1-12, 2015 | 227 | 2015 |
| Particle toxicology and health-where are we? M Riediker, D Zink, W Kreyling, G Oberdörster, A Elder, U Graham, ... Particle and fibre toxicology 16, 1-33, 2019 | 219 | 2019 |
| Mechanistically identified suitable biomarkers of exposure, effect, and susceptibility for silicosis and coal-worker's pneumoconiosis: a comprehensive review M Gulumian, PJA Borm, V Vallyathan, V Castranova, K Donaldson, ... Journal of Toxicology and Environmental Health, Part B 9 (5), 357-395, 2006 | 192 | 2006 |
| Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis V Steenkamp, MC Gouws, M Gulumian, EE Elgorashi, J Van Staden Journal of Ethnopharmacology 103 (1), 71-75, 2006 | 160 | 2006 |
| Challenges facing sterilization and depyrogenation of nanoparticles: Effects on structural stability and biomedical applications MA Vetten, CS Yah, T Singh, M Gulumian Nanomedicine: Nanotechnology, Biology and Medicine 10 (7), 1391-1399, 2014 | 159 | 2014 |
| The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles K Donaldson, PJA Borm, V Castranova, M Gulumian Particle and fibre toxicology 6, 1-8, 2009 | 147 | 2009 |
| Label-free in vitro toxicity and uptake assessment of citrate stabilised gold nanoparticles in three cell lines MA Vetten, N Tlotleng, D Tanner Rascher, A Skepu, FK Keter, K Boodhia, ... Particle and fibre toxicology 10, 1-15, 2013 | 143 | 2013 |
| NanoSolveIT Project: Driving nanoinformatics research to develop innovative and integrated tools for in silico nanosafety assessment A Afantitis, G Melagraki, P Isigonis, A Tsoumanis, DD Varsou, ... Computational and Structural Biotechnology Journal 18, 583-602, 2020 | 109 | 2020 |
| Risk assessment of benzene, toluene, ethyl benzene, and xylene concentrations from the combustion of coal in a controlled laboratory environment MD Masekameni, R Moolla, M Gulumian, D Brouwer International journal of environmental research and public health 16 (1), 95, 2019 | 103 | 2019 |
| Size-dependent clearance of gold nanoparticles from lungs of Sprague–Dawley rats after short-term inhalation exposure SG Han, JS Lee, K Ahn, YS Kim, JK Kim, JH Lee, JH Shin, KS Jeon, ... Archives of toxicology 89, 1083-1094, 2015 | 97 | 2015 |
| Hazards identified and the need for health risk assessment in the South African mining industry W Utembe, EM Faustman, P Matatiele, M Gulumian Human & experimental toxicology 34 (12), 1212-1221, 2015 | 90 | 2015 |
| From the Cover: An Investigation of the Genotoxicity and Interference of Gold Nanoparticles in Commonly Used In Vitro Mutagenicity and Genotoxicity Assays JM George, M Magogotya, MA Vetten, AV Buys, M Gulumian Toxicological Sciences 156 (1), 149-166, 2017 | 70 | 2017 |
| Toward rigorous materials production: New approach methodologies have extensive potential to improve current safety assessment practices P Nymark, M Bakker, S Dekkers, R Franken, W Fransman, ... Small 16 (6), 1904749, 2020 | 63 | 2020 |
| Antioxidant and genotoxic properties of South African herbal extracts V Steenkamp, H Grimmer, M Semano, M Gulumian Mutation Research/Genetic Toxicology and Environmental Mutagenesis 581 (1-2 …, 2005 | 58 | 2005 |
| Transcriptomics in toxicogenomics, part I: experimental design, technologies, publicly available data, and regulatory aspects PAS Kinaret, A Serra, A Federico, P Kohonen, P Nymark, I Liampa, MK Ha, ... Nanomaterials 10 (4), 750, 2020 | 57 | 2020 |
| Transcriptomics in toxicogenomics, part III: data modelling for risk assessment A Serra, M Fratello, L Cattelani, I Liampa, G Melagraki, P Kohonen, ... Nanomaterials 10 (4), 708, 2020 | 54 | 2020 |
| Cytotoxicity, intracellular localization and exocytosis of citrate capped and PEG functionalized gold nanoparticles in human hepatocyte and kidney cells N Tlotleng, MA Vetten, FK Keter, A Skepu, R Tshikhudo, M Gulumian Cell biology and toxicology 32, 305-321, 2016 | 54 | 2016 |
| Current approaches and techniques in physiologically based pharmacokinetic (PBPK) modelling of nanomaterials W Utembe, H Clewell, N Sanabria, P Doganis, M Gulumian Nanomaterials 10 (7), 1267, 2020 | 53 | 2020 |
| The role of oxidative stress in diseases caused by mineral dusts and fibres: current status and future of prophylaxis and treatment M Gulumian Stress Adaptation, Prophylaxis and Treatment, 69-77, 1999 | 50 | 1999 |
